Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Study Drug Disposition	STARTED	Cefepime/VNRX-5133 (Taniborbactam)	441
Study Drug Disposition	STARTED	Meropenem	220
Study Drug Disposition	COMPLETED	Cefepime/VNRX-5133 (Taniborbactam)	414
Study Drug Disposition	COMPLETED	Meropenem	212
Study Drug Disposition	NOT COMPLETED	Cefepime/VNRX-5133 (Taniborbactam)	27
Study Drug Disposition	NOT COMPLETED	Meropenem	8
Study Completion Disposition	STARTED	Cefepime/VNRX-5133 (Taniborbactam)	441
Study Completion Disposition	STARTED	Meropenem	220
Study Completion Disposition	COMPLETED	Cefepime/VNRX-5133 (Taniborbactam)	426
Study Completion Disposition	COMPLETED	Meropenem	214
Study Completion Disposition	NOT COMPLETED	Cefepime/VNRX-5133 (Taniborbactam)	15
Study Completion Disposition	NOT COMPLETED	Meropenem	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03840148/flow